These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22635102)

  • 21. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.
    Hiltunen M; van Groen T; Jolkkonen J
    J Alzheimers Dis; 2009; 18(2):401-12. PubMed ID: 19584429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metals in Alzheimer's and Parkinson's diseases.
    Barnham KJ; Bush AI
    Curr Opin Chem Biol; 2008 Apr; 12(2):222-8. PubMed ID: 18342639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper and Zinc Dysregulation in Alzheimer's Disease.
    Sensi SL; Granzotto A; Siotto M; Squitti R
    Trends Pharmacol Sci; 2018 Dec; 39(12):1049-1063. PubMed ID: 30352697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of metal dyshomeostasis in Alzheimer's disease.
    Bonda DJ; Lee HG; Blair JA; Zhu X; Perry G; Smith MA
    Metallomics; 2011 Mar; 3(3):267-70. PubMed ID: 21298161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal chelation as a potential therapy for Alzheimer's disease.
    Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
    Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice.
    Akiyama H; Hosokawa M; Kametani F; Kondo H; Chiba M; Fukushima M; Tabira T
    Neuropathology; 2012 Aug; 32(4):390-7. PubMed ID: 22118300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sub-lethal levels of amyloid β-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons.
    SanMartín CD; Paula-Lima AC; Hidalgo C; Núñez MT
    Biometals; 2012 Aug; 25(4):805-13. PubMed ID: 22526560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.
    Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A
    Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
    Mandel S; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2007 Aug; 82(6):348-60. PubMed ID: 17659826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper brain homeostasis: role of amyloid precursor protein and prion protein.
    Inestrosa NC; Cerpa W; Varela-Nallar L
    IUBMB Life; 2005 Sep; 57(9):645-50. PubMed ID: 16203684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingolipids: critical players in Alzheimer's disease.
    van Echten-Deckert G; Walter J
    Prog Lipid Res; 2012 Oct; 51(4):378-93. PubMed ID: 22835784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
    Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
    Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.
    Lei P; Ayton S; Finkelstein DI; Spoerri L; Ciccotosto GD; Wright DK; Wong BX; Adlard PA; Cherny RA; Lam LQ; Roberts BR; Volitakis I; Egan GF; McLean CA; Cappai R; Duce JA; Bush AI
    Nat Med; 2012 Jan; 18(2):291-5. PubMed ID: 22286308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
    Castellani RJ; Honda K; Zhu X; Cash AD; Nunomura A; Perry G; Smith MA
    Ageing Res Rev; 2004 Jul; 3(3):319-26. PubMed ID: 15231239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.